Investors

Investor Information

ICON is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives.

Our services can be implemented separately or as part of a comprehensive full service clinical programme that can help expedite the time it takes to bring a drug to market and monitor its performance and safety post approval.

Share Price NASDAQ

Price

Change

High

Minimum 15 minutes delayed. Source:


Recent News

Oct 23, 2024 ICON Reports Third Quarter 2024 Results

Recent News

Oct 23, 2024

ICON Reports Third Quarter 2024 Results


Upcoming Events

More events are coming soon.

Upcoming Events

More events are coming soon.


Investing in ICON

Learn more about which Industry Analysts cover ICON and other investment information.

Investing in ICON

Learn more about which Industry Analysts cover ICON and other investment information.



Search Investor